Share
- Release Date: 18/06/13 17:52
- Summary: S/HOLDER: EBO: EBOS Share Entitlement - Reminder Letter Action Required
- Price Sensitive: No
- Download Document 2.85KB
EBO
18/06/2013 15:52
S/HOLDER
REL: 1552 HRS Ebos Group Limited
S/HOLDER: EBO: EBOS Share Entitlement - Reminder Letter Action Required
17 June 2013
Dear Shareholder,
EBOS Share Entitlement - Action Required
At a Special Meeting held in Christchurch last Friday (14 June 2013),
Shareholders voted overwhelmingly to approve the acquisition by EBOS Group
Limited of Zuellig Healthcare Holdings Australia Pty Limited ("Symbion").
The acquisition will establish EBOS as Australasia's leading supply and
distribution platform for pharmaceutical products in both Australia and New
Zealand by revenue, with a diversified Australasian animal care offering.
As part of the financing of this acquisition, EBOS announced an underwritten
entitlement offer to all eligible shareholders on 29 May 2013. You will have
received a letter detailing your Entitlement to subscribe for New Shares
along with a copy of the Offer Document for the Entitlement Offer. If you
have not received details of your Entitlement or the Offer Document, please
immediately call Computershare information hotline on 0800 835 625 (within
New Zealand).
IT IS VERY IMPORTANT THAT ALL SHAREHOLDERS TAKE ACTION REGARDING THE
ENTITLEMENT OFFER. EITHER:
- TAKE UP YOUR ENTITLEMENT TO SUBCRIBE FOR NEW SHARES by 1 July 2013
- OR SELL YOUR ENTITLEMENT TO THE NEW SHARES by 25 June 2013 if you wish to
sell some or all of your Entitlements on the NZX Main Board
Although the Closing Date is 1 July 2013, EBOS encourages Shareholders
wishing to accept the Entitlement Offer to do so promptly, to ensure your
application is processed and your payment cleared. EBOS encourages you to
make payment by direct credit.
DOING NOTHING MEANS YOU ARE LIKELY TO LOSE VALUE
ACT NOW!
We encourage you to read the Offer Document carefully before making your
investment decision. Section 5 "Details of the Offer and Answers to
Important Questions" on pages 9-12 of the Offer Document and section 14 "What
You Need To Do Next" on page 60 explains the actions required. If you are
unsure what to do, we strongly recommend you contact your investment adviser
or call the Computershare information hotline on 0800 835 625 (within New
Zealand).
If you were a registered Shareholder at 5pm on 14 June 2013 and your address
in the EBOS share register is in New Zealand or Australia, you are an
Eligible Shareholder for the Entitlement Offer. If you accept your
Entitlement in full and your registered address is in New Zealand, you are
also entitled to apply for Additional New Shares through the Oversubscription
Facility described in the Offer Document.
The Board is confident that the addition of Symbion will bring further
diversification to the EBOS business and opportunities for further earnings
growth.
Thank you for your support.
Yours sincerely,
Dennis Doherty
Chief Financial Officer
End CA:00237557 For:EBO Type:S/HOLDER Time:2013-06-18 15:52:30
